Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

[1]  E. Campo,et al.  Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia , 2018, Haematologica.

[2]  J. Byrd,et al.  iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. , 2018, Blood.

[3]  M. Cazzola,et al.  Time-dependent changes in mortality and transformation risk in MDS. , 2016, Blood.

[4]  K. Stamatopoulos,et al.  Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. , 2016, Blood.

[5]  G. Fabbri,et al.  The molecular pathogenesis of chronic lymphocytic leukaemia , 2016, Nature Reviews Cancer.

[6]  R. Rosenquist,et al.  The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia. , 2015, Seminars in cancer biology.

[7]  Lefteris Angelis,et al.  Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. , 2014, The Lancet. Haematology.

[8]  E. Campo,et al.  Recurrent mutations refine prognosis in chronic lymphocytic leukemia , 2014, Leukemia.

[9]  Gang Han,et al.  Improved survival modeling in cancer research using a reduced piecewise exponential approach , 2014, Statistics in medicine.

[10]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[11]  D. Collet.  Modelling Survival Data in Medical Research , 2004 .

[12]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[13]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[14]  Mary M. Reilly,et al.  bshazard: A Flexible Tool for Nonparametric Smoothing of the Hazard Function , 2014, R J..

[15]  R. Dalla‐Favera,et al.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. , 2013, Blood.